|Articles|October 15, 2009
Emerging Leadership Awards- Virginia Carnahan
Advertisement
Virginia Carnahan,
Vice President, New Product Planning and Strategy,
Vertex Pharmaceuticals
Download Adobe Flash Player
Virginia Carnahan, vice president of new product planning and strategy at Vertex Pharmaceuticals, reflects on the industry’s changing environment and how to adapt to remain competitive.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Datroway for Patients with Metastatic Triple-Negative Breast Cancer Who Are Not PD-1/PD-L1 Inhibitor Candidates
2
Eli Lilly and Novo Nordisk Shift Patients From Compounded Drugs to Lower-Cost Weight-Loss Pills: Report
3
The Evolving Relationship Between FDA and Biotech
4
What Kinds of Disruption are GLP-1s Expected to Face
5